Report Detail
Global Hereceptin Biosimilars Market Professional Survey Report 2019
- RnM3768647 |
- 20 September, 2019 |
- Global |
- 109 Pages |
- QYResearch |
- Pharma & Healthcare
Herceptin, also known as trastuzumab, is used as a medication for patients who suffer from cancer, which assists in controlling the growth and spread of cancer cells in the body. Herceptin biosimilars are essentially used to treat certain breast as well stomach cancers, and is also used in combination with other medicines for treatment.
The global Hereceptin Biosimilars market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Hereceptin Biosimilars volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hereceptin Biosimilars market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Hereceptin Biosimilars in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Hereceptin Biosimilars manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Mylan N.V
Amgen Inc.
Mabion S.A.
AryoGen Biopharma
Genor Biopharma
Celltrion Inc.
Gedeon Richter
The Instituto Vital Brazil
F. Hoffmann-La Roche AG
Biocons
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Capsule
Tablet
Others
Segment by Application
Healthcare & Pharmaceuticals
Personal Care
Others
Table of Contents
Executive Summary
1 Industry Overview of Hereceptin Biosimilars
- 1.1 Definition of Hereceptin Biosimilars
- 1.2 Hereceptin Biosimilars Segment by Type
- 1.2.1 Global Hereceptin Biosimilars Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Capsule
- 1.2.3 Tablet
- 1.2.4 Others
- 1.3 Hereceptin Biosimilars Segment by Applications
- 1.3.1 Global Hereceptin Biosimilars Consumption Comparison by Applications (2014-2025)
- 1.3.2 Healthcare & Pharmaceuticals
- 1.3.3 Personal Care
- 1.3.4 Others
- 1.4 Global Hereceptin Biosimilars Overall Market
- 1.4.1 Global Hereceptin Biosimilars Revenue (2014-2025)
- 1.4.2 Global Hereceptin Biosimilars Production (2014-2025)
- 1.4.3 North America Hereceptin Biosimilars Status and Prospect (2014-2025)
- 1.4.4 Europe Hereceptin Biosimilars Status and Prospect (2014-2025)
- 1.4.5 China Hereceptin Biosimilars Status and Prospect (2014-2025)
- 1.4.6 Japan Hereceptin Biosimilars Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Hereceptin Biosimilars Status and Prospect (2014-2025)
- 1.4.8 India Hereceptin Biosimilars Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Hereceptin Biosimilars
- 2.3 Manufacturing Process Analysis of Hereceptin Biosimilars
- 2.4 Industry Chain Structure of Hereceptin Biosimilars
3 Development and Manufacturing Plants Analysis of Hereceptin Biosimilars
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Hereceptin Biosimilars Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Hereceptin Biosimilars
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Hereceptin Biosimilars Production and Capacity Analysis
- 4.2 Hereceptin Biosimilars Revenue Analysis
- 4.3 Hereceptin Biosimilars Price Analysis
- 4.4 Market Concentration Degree
5 Hereceptin Biosimilars Regional Market Analysis
- 5.1 Hereceptin Biosimilars Production by Regions
- 5.1.1 Global Hereceptin Biosimilars Production by Regions
- 5.1.2 Global Hereceptin Biosimilars Revenue by Regions
- 5.2 Hereceptin Biosimilars Consumption by Regions
- 5.3 North America Hereceptin Biosimilars Market Analysis
- 5.3.1 North America Hereceptin Biosimilars Production
- 5.3.2 North America Hereceptin Biosimilars Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Hereceptin Biosimilars Import and Export
- 5.4 Europe Hereceptin Biosimilars Market Analysis
- 5.4.1 Europe Hereceptin Biosimilars Production
- 5.4.2 Europe Hereceptin Biosimilars Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Hereceptin Biosimilars Import and Export
- 5.5 China Hereceptin Biosimilars Market Analysis
- 5.5.1 China Hereceptin Biosimilars Production
- 5.5.2 China Hereceptin Biosimilars Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Hereceptin Biosimilars Import and Export
- 5.6 Japan Hereceptin Biosimilars Market Analysis
- 5.6.1 Japan Hereceptin Biosimilars Production
- 5.6.2 Japan Hereceptin Biosimilars Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Hereceptin Biosimilars Import and Export
- 5.7 Southeast Asia Hereceptin Biosimilars Market Analysis
- 5.7.1 Southeast Asia Hereceptin Biosimilars Production
- 5.7.2 Southeast Asia Hereceptin Biosimilars Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Hereceptin Biosimilars Import and Export
- 5.8 India Hereceptin Biosimilars Market Analysis
- 5.8.1 India Hereceptin Biosimilars Production
- 5.8.2 India Hereceptin Biosimilars Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Hereceptin Biosimilars Import and Export
6 Hereceptin Biosimilars Segment Market Analysis (by Type)
- 6.1 Global Hereceptin Biosimilars Production by Type
- 6.2 Global Hereceptin Biosimilars Revenue by Type
- 6.3 Hereceptin Biosimilars Price by Type
7 Hereceptin Biosimilars Segment Market Analysis (by Application)
- 7.1 Global Hereceptin Biosimilars Consumption by Application
- 7.2 Global Hereceptin Biosimilars Consumption Market Share by Application (2014-2019)
8 Hereceptin Biosimilars Major Manufacturers Analysis
- 8.1 Mylan N.V
- 8.1.1 Mylan N.V Hereceptin Biosimilars Production Sites and Area Served
- 8.1.2 Mylan N.V Product Introduction, Application and Specification
- 8.1.3 Mylan N.V Hereceptin Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Amgen Inc.
- 8.2.1 Amgen Inc. Hereceptin Biosimilars Production Sites and Area Served
- 8.2.2 Amgen Inc. Product Introduction, Application and Specification
- 8.2.3 Amgen Inc. Hereceptin Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Mabion S.A.
- 8.3.1 Mabion S.A. Hereceptin Biosimilars Production Sites and Area Served
- 8.3.2 Mabion S.A. Product Introduction, Application and Specification
- 8.3.3 Mabion S.A. Hereceptin Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 AryoGen Biopharma
- 8.4.1 AryoGen Biopharma Hereceptin Biosimilars Production Sites and Area Served
- 8.4.2 AryoGen Biopharma Product Introduction, Application and Specification
- 8.4.3 AryoGen Biopharma Hereceptin Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Genor Biopharma
- 8.5.1 Genor Biopharma Hereceptin Biosimilars Production Sites and Area Served
- 8.5.2 Genor Biopharma Product Introduction, Application and Specification
- 8.5.3 Genor Biopharma Hereceptin Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Celltrion Inc.
- 8.6.1 Celltrion Inc. Hereceptin Biosimilars Production Sites and Area Served
- 8.6.2 Celltrion Inc. Product Introduction, Application and Specification
- 8.6.3 Celltrion Inc. Hereceptin Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Gedeon Richter
- 8.7.1 Gedeon Richter Hereceptin Biosimilars Production Sites and Area Served
- 8.7.2 Gedeon Richter Product Introduction, Application and Specification
- 8.7.3 Gedeon Richter Hereceptin Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 The Instituto Vital Brazil
- 8.8.1 The Instituto Vital Brazil Hereceptin Biosimilars Production Sites and Area Served
- 8.8.2 The Instituto Vital Brazil Product Introduction, Application and Specification
- 8.8.3 The Instituto Vital Brazil Hereceptin Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 F. Hoffmann-La Roche AG
- 8.9.1 F. Hoffmann-La Roche AG Hereceptin Biosimilars Production Sites and Area Served
- 8.9.2 F. Hoffmann-La Roche AG Product Introduction, Application and Specification
- 8.9.3 F. Hoffmann-La Roche AG Hereceptin Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Biocons
- 8.10.1 Biocons Hereceptin Biosimilars Production Sites and Area Served
- 8.10.2 Biocons Product Introduction, Application and Specification
- 8.10.3 Biocons Hereceptin Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
9 Development Trend of Analysis of Hereceptin Biosimilars Market
- 9.1 Global Hereceptin Biosimilars Market Trend Analysis
- 9.1.1 Global Hereceptin Biosimilars Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Hereceptin Biosimilars Regional Market Trend
- 9.2.1 North America Hereceptin Biosimilars Forecast 2019-2025
- 9.2.2 Europe Hereceptin Biosimilars Forecast 2019-2025
- 9.2.3 China Hereceptin Biosimilars Forecast 2019-2025
- 9.2.4 Japan Hereceptin Biosimilars Forecast 2019-2025
- 9.2.5 Southeast Asia Hereceptin Biosimilars Forecast 2019-2025
- 9.2.6 India Hereceptin Biosimilars Forecast 2019-2025
- 9.3 Hereceptin Biosimilars Market Trend (Product Type)
- 9.4 Hereceptin Biosimilars Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Hereceptin Biosimilars Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Hereceptin Biosimilars. Industry analysis & Market Report on Hereceptin Biosimilars is a syndicated market report, published as Global Hereceptin Biosimilars Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Hereceptin Biosimilars market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
